All News

2019

November

Media Release / Nov 13, 2019

Novartis announces new strategy to provide innovative medicines to more patients in sub-Saharan Africa

Read More
Media Release / Nov 12, 2019

Sandoz presents real-world data showing effectiveness of Erelzi® (etanercept-szzs) in rheumatic disease treatment

Read More
Media Release / Nov 12, 2019

New Novartis PREVENT data show Cosentyx® delivers early relief in axial spondyloarthritis

Read More
Media Release / Nov 11, 2019

Novartis data show tropifexor (LJN452) significantly improves several key biomarkers of NASH in patients with moderate to severe fibrosis

Read More
Media Release / Nov 11, 2019

Sandoz announces agreement to acquire Aspen’s Japanese operations and associated assets, strengthening position in world’s third largest generics market

Read More
Media Release / Nov 05, 2019

Sandoz receives US FDA approval for long-acting oncology supportive care biosimilar Ziextenzo™ (pegfilgrastim-bmez)

Read More
Media Release / Nov 01, 2019

Novartis Cosentyx® shows encouraging results versus Humira®* from first-of-its-kind head-to-head trial in psoriatic arthritis

Read More

October

Media Release / Oct 30, 2019

Novartis announces AVXS-101 intrathecal study update

Read More
Media Release / Oct 24, 2019

Novartis receives approval for Cosentyx® label update in Europe to include dosing flexibility in ankylosing spondylitis

Read More
Media Release / Oct 22, 2019

Novartis delivered another strong quarter with double digit sales growth and core margin expansion; 2019 sales and profit guidance raised; Beovu launched in US

Read More

Related Links

Novartis Annual Reporting Suite

Read and download the Annual Review, the Annual Report and Form 20-F, and the Novartis in Society report.

Learn More